|
|
||||||||
UCLA School of Medicine and the University of California at Los Angeles, Los Angeles, California
Correspondence: For reprints contact: Michael E. Phelps, PhD, Div. of Biophysics, Dept. of Radiological Sciences, UCLA School of Medicine, Los Angeles, CA 90024.
ABSTRACT
The deoxyglucose method originally developed for measurements of the local cerebral metabolic rate for glucose has been investigated in terms of its application to cardiac studies with positron computed tomography (PCT) and fluorodeoxy-glucose (FDG). Studies were performed in dogs to measure the tissue kinetics of FDG with PCT and by arterial and venous sampling. The operational equation developed in our laboratory as an extension of the Sokoloff model was used to analyze the data. Error propagation, primarily from corrections applied to remove spillover of activity from the myocardial blood pool to tissue and from partial-volume effects In the PCT Images, limited accuracy in the estimation of the individual rate constants for transport, phosphorylation, and dephosphorylation. However, a constant representing the combination of transport and phosphorylation was accurately determined and yielded measured values of the myocardial metabolic rate for glucose (MMRGIc) that were in good agreement with direct determinations using the Fick method over a wide range of glucose metabolic rates (from 1.7 to 21.1 mg/min-100g). The lumped constant (0.67 ± 0.10) was also found accurate and stable over this range of metabolism. The FDG method accurately predicted the true MMRGIc even when the glucose metabolic rate was normal but myocardial blood flow (MBF) was five times the control value, or when metabolism was reduced to 10% of normal and MBF increased to five times normal. Improvements of PCT resolution are required to improve the accuracy of the estimates of the rate constants and the MMRGIc.
This article has been cited by other articles:
![]() |
L. Stegger, A.-N. Hoffmeier, K. P. Schafers, S. Hermann, O. Schober, M. A. Schafers, and G. Theilmeier Accurate Noninvasive Measurement of Infarct Size in Mice with High-Resolution PET J. Nucl. Med., November 1, 2006; 47(11): 1837 - 1844. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Stegger, K. P. Schafers, U. Flogel, L. Livieratos, S. Hermann, C. Jacoby, P. Keul, E. M. Conway, O. Schober, J. Schrader, et al. Monitoring Left Ventricular Dilation in Mice with PET J. Nucl. Med., September 1, 2005; 46(9): 1516 - 1521. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ishimaru, I. Tsujino, T. Takei, E. Tsukamoto, S. Sakaue, M. Kamigaki, N. Ito, H. Ohira, D. Ikeda, N. Tamaki, et al. Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis Eur. Heart J., August 1, 2005; 26(15): 1538 - 1543. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bertoldo, J. Price, C. Mathis, S. Mason, D. Holt, C. Kelley, C. Cobelli, and D. E. Kelley Quantitative Assessment of Glucose Transport in Human Skeletal Muscle: Dynamic Positron Emission Tomography Imaging of [O-Methyl-11C]3-O-Methyl-D-Glucose J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1752 - 1759. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Shoup, D. R. Elmaleh, A. A. Bonab, and A. J. Fischman Evaluation of trans-9-18F-Fluoro-3,4-Methyleneheptadecanoic Acid as a PET Tracer for Myocardial Fatty Acid Imaging J. Nucl. Med., February 1, 2005; 46(2): 297 - 304. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Okumura, T. Iwasaki, T. Toyama, T. Iso, M. Arai, N. Oriuchi, K. Endo, T. Yokoyama, T. Suzuki, and M. Kurabayashi Usefulness of Fasting 18F-FDG PET in Identification of Cardiac Sarcoidosis J. Nucl. Med., December 1, 2004; 45(12): 1989 - 1998. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. O. McFalls, M. Hou, R. J. Bache, A. Best, D. Marx, J. Sikora, and H. B. Ward Activation of p38 MAPK and increased glucose transport in chronic hibernating swine myocardium Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1328 - H1334. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. O. McFalls, B. Murad, D. Her, J.-S. Liow, R. Kelly, D. Marx, J. Sikora, and H. B. Ward Repetitive Supply-Demand Ischemia with Dobutamine Increases Glucose Uptake in Postischemic and Remote Myocardium J. Nucl. Med., January 1, 2003; 44(1): 85 - 91. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Herrero, T. L. Sharp, C. Dence, B. M. Haraden, and R. J. Gropler Comparison of 1-11C-Glucose and 18F-FDG for Quantifying Myocardial Glucose Use with PET J. Nucl. Med., November 1, 2002; 43(11): 1530 - 1541. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. O. McFalls, B. Murad, J.-S. Liow, M. C. Gannon, H. C. Haspel, A. Lange, D. Marx, J. Sikora, and H. B. Ward Glucose uptake and glycogen levels are increased in pig heart after repetitive ischemia Am J Physiol Heart Circ Physiol, January 1, 2002; 282(1): H205 - H211. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Vitale, R. A. deKemp, T. D. Ruddy, K. Williams, and R. S.B. Beanlands Myocardial Glucose Utilization and Optimization of 18F-FDG PET Imaging in Patients with Non-Insulin-Dependent Diabetes Mellitus, Coronary Artery Disease, and Left Ventricular Dysfunction J. Nucl. Med., December 1, 2001; 42(12): 1730 - 1736. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. van der Weerdt, L. J. Klein, R. Boellaard, C. A. Visser, F. C. Visser, and A. A. Lammertsma Image-Derived Input Functions for Determination of MRGlu in Cardiac 18F-FDG PET Scans J. Nucl. Med., November 1, 2001; 42(11): 1622 - 1629. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Cranston, L. J. Reed, P. K. Marsden, and S. A. Amiel Changes in Regional Brain 18F-Fluorodeoxyglucose Uptake at Hypoglycemia in Type 1 Diabetic Men Associated With Hypoglycemia Unawareness and Counter-Regulatory Failure Diabetes, October 1, 2001; 50(10): 2329 - 2366. [Abstract] [Full Text] |
||||
![]() |
M. Taylor, T. R. Wallhaus, T. R. DeGrado, D. C. Russell, P. Stanko, R. J. Nickles, and C. K. Stone An Evaluation of Myocardial Fatty Acid and Glucose Uptake Using PET with [18F]Fluoro-6-Thia-Heptadecanoic Acid and [18F]FDG in Patients with Congestive Heart Failure J. Nucl. Med., January 1, 2001; 42(1): 55 - 62. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. F. Kofoed, H. Schoder, R. J. Knight, and D. B. Buxton Glucose metabolism in reperfused myocardium measured by [2-18F] 2-fluorodeoxyglucose and PET Cardiovasc Res, January 14, 2000; 45(2): 321 - 329. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. O. McFalls, D. Baldwin, D. Marx, P. Fashingbauer, and H. B. Ward Effect of regional hyperemia on myocardial uptake of 2-deoxy-2-[18F]fluoro-D-glucose Am J Physiol Endocrinol Metab, January 1, 2000; 278(1): E96 - E102. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L'Abbate, G. Sambuceti, S. Haunso, and J. Schneider-Eicke Methods for evaluating coronary microvasculature in humans Eur. Heart J., September 2, 1999; 20(18): 1300 - 1313. [PDF] |
||||
![]() |
C. Depre, J.-L. J. Vanoverschelde, and H. Taegtmeyer Glucose for the Heart Circulation, February 2, 1999; 99(4): 578 - 588. [Full Text] [PDF] |
||||
![]() |
K. Hashimoto, T. Nishimura, K.-I. Imahashi, H. Yamaguchi, M. Hori, and H. Kusuoka Lumped constant for deoxyglucose is decreased when myocardial glucose uptake is enhanced Am J Physiol Heart Circ Physiol, January 1, 1999; 276(1): H129 - H133. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Marshall, P. Powers-Risius, R. H. Huesman, B. W. Reutter, S. E. Taylor, H. E. Maurer, M. K. Huesman, and T. F. Budinger Estimating glucose metabolism using glucose analogs and two tracer kinetic models in isolated rabbit heart Am J Physiol Heart Circ Physiol, August 1, 1998; 275(2): H668 - H679. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Mobilia, P. Zanco, A. Desideri, G. Neri, F. Alitto, G. Suzzi, F. Chierichetti, L. Celegon, G. Ferlin, and R. Buchberger T wave normalization in infarct-related electrocardiographic leads during exercise testing for detection of residual viability: comparison with positron emission tomography J. Am. Coll. Cardiol., July 1, 1998; 32(1): 75 - 82. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Doenst and H. Taegtmeyer Profound Underestimation of Glucose Uptake by [18F]2-Deoxy-2-fluoroglucose in Reperfused Rat Heart Muscle Circulation, June 23, 1998; 97(24): 2454 - 2462. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Matsumura, R. W. Jeremy, J. Schaper, and L. C. Becker Progression of Myocardial Necrosis During Reperfusion of Ischemic Myocardium Circulation, March 3, 1998; 97(8): 795 - 804. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Fallavollita, B. J. Perry, and J. M. Canty Jr 18F-2-Deoxyglucose Deposition and Regional Flow in Pigs With Chronically Dysfunctional Myocardium : Evidence for Transmural Variations in Chronic Hibernating Myocardium Circulation, April 1, 1997; 95(7): 1900 - 1909. [Abstract] [Full Text] |
||||
![]() |
K. T. Sun, J. Czernin, J. Krivokapich, Y.-K. Lau, M. Bottcher, G. Maurer, M. E. Phelps, and H. R. Schelbert Effects of Dobutamine Stimulation on Myocardial Blood Flow, Glucose Metabolism, and Wall Motion in Normal and Dysfunctional Myocardium Circulation, December 15, 1996; 94(12): 3146 - 3154. [Abstract] [Full Text] |
||||
![]() |
M. Maki, M. Luotolahti, P. Nuutila, H. Iida, L.-M. Voipio-Pulkki, U. Ruotsalainen, M. Haaparanta, O. Solin, J. Hartiala, R. Harkonen, et al. Glucose Uptake in the Chronically Dysfunctional but Viable Myocardium Circulation, May 1, 1996; 93(9): 1658 - 1666. [Abstract] [Full Text] |
||||
![]() |
J. Zhang, D. J. Duncker, X. Ya, Y. Zhang, T. Pavek, H. Wei, H. Merkle, K. Ugurbil, A. H. L. From, and R. J. Bache Effect of Left Ventricular Hypertrophy Secondary to Chronic Pressure Overload on Transmural Myocardial 2-Deoxyglucose Uptake : A 31P NMR Spectroscopic Study Circulation, September 1, 1995; 92(5): 1274 - 1283. [Abstract] [Full Text] |
||||
![]() |
R. Hariharan, M. Bray, R. Ganim, T. Doenst, G. W. Goodwin, and H. Taegtmeyer Fundamental Limitations of [18F]2-Deoxy-2-Fluoro-D-Glucose for Assessing Myocardial Glucose Uptake Circulation, May 1, 1995; 91(9): 2435 - 2444. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |